Catalysts for Prinston Pharmaceutical Inc
34 tracked
Mar 6, 2026
approval
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 5, 2026
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Mar 5, 2026
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Feb 17, 2026
approval
TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Feb 17, 2026
approval
TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Feb 17, 2026
approval
TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Feb 17, 2026
approval
TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 15, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Nov 28, 2025
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Dec 20, 2023
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Feb 23, 2023
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Feb 23, 2023
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Feb 23, 2023
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Jan 31, 2022
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Dec 30, 2021
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 8, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Dec 8, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
May 21, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
May 21, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Jun 2, 2020
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Nov 6, 2017
approval
TELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Sep 19, 2017
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Sep 22, 2016
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Sep 20, 2016
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Prinston Pharmaceutical Inc
→
Apr 28, 2015
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→